- Home
- ISPR vs INO Comparison
ISPR vs INO Comparison
Compare ISPR & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ISPR
- INO
- Stock Information
- Founded
- ISPR 2010
- INO 1979
- Country
- ISPR United States
- INO United States
- Employees
- ISPR N/A
- INO N/A
- Industry
- ISPR Medicinal Chemicals and Botanical Products
- INO Medical/Dental Instruments
- Sector
- ISPR Health Care
- INO Health Care
- Exchange
- ISPR Nasdaq
- INO Nasdaq
- Market Cap
- ISPR 126.0M
- INO 136.6M
- IPO Year
- ISPR 2023
- INO 1998
- Fundamental
- Price
- ISPR $2.26
- INO $2.43
- Analyst Decision
- ISPR Strong Buy
- INO Buy
- Analyst Count
- ISPR 1
- INO 5
- Target Price
- ISPR $7.50
- INO $8.80
- AVG Volume (30 Days)
- ISPR 45.3K
- INO 1.1M
- Earning Date
- ISPR 11-12-2025
- INO 11-10-2025
- Dividend Yield
- ISPR N/A
- INO N/A
- EPS Growth
- ISPR N/A
- INO N/A
- EPS
- ISPR N/A
- INO N/A
- Revenue
- ISPR $127,494,304.00
- INO $182,337.00
- Revenue This Year
- ISPR $60.96
- INO N/A
- Revenue Next Year
- ISPR $23.96
- INO $14,751.49
- P/E Ratio
- ISPR N/A
- INO N/A
- Revenue Growth
- ISPR N/A
- INO N/A
- 52 Week Low
- ISPR $2.06
- INO $1.30
- 52 Week High
- ISPR $7.47
- INO $5.80
- Technical
- Relative Strength Index (RSI)
- ISPR 42.61
- INO 51.53
- Support Level
- ISPR $2.31
- INO $2.21
- Resistance Level
- ISPR $2.65
- INO $2.49
- Average True Range (ATR)
- ISPR 0.18
- INO 0.15
- MACD
- ISPR -0.00
- INO -0.01
- Stochastic Oscillator
- ISPR 33.90
- INO 47.74
About ISPR Ispire Technology Inc.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.